Trials / Completed
CompletedNCT04090047
A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants
A PHASE 1, OPEN-LABEL, FIXED SEQUENCE 2-PERIOD STUDY TO INVESTIGATE THE EFFECT OF MULTIPLE DOSES OF ITRACONAZOLE ON THE PHARMACOKINETICS OF A SINGLE DOSE OF PF-06700841 IN HEALTHY PARTICIPANTS
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
An open-label, fixed-sequence, 2-period study to investigate the effect of multiple oral doses of itraconazole on a single oral dose of PF-06700841 PK in healthy participants. The study will consist of two treatment periods in one fixed sequence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-06700841 | PF-06700841 oral tablets in 5mg and 25mg provided for a 30mg dose |
| DRUG | Itraconazole | 200 mg oral solution administered as 20 milliliters(mL) (10 mg/mL) |
Timeline
- Start date
- 2019-09-24
- Primary completion
- 2019-12-19
- Completion
- 2019-12-19
- First posted
- 2019-09-16
- Last updated
- 2020-01-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04090047. Inclusion in this directory is not an endorsement.